These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12852717)

  • 1. Infliximab therapy in Crohn's disease: safety issues.
    Hommes DW; van Deventer SJ
    Neth J Med; 2003 Apr; 61(4):100-4. PubMed ID: 12852717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety aspects of infliximab in inflammatory bowel disease patients. A retrospective cohort study in 100 patients of a German University Hospital.
    Seiderer J; Göke B; Ochsenkühn T
    Digestion; 2004; 70(1):3-9. PubMed ID: 15297773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
    Rutgeerts P; Van Assche G; Vermeire S
    Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.
    Hyder SA; Travis SP; Jewell DP; McC Mortensen NJ; George BD
    Dis Colon Rectum; 2006 Dec; 49(12):1837-41. PubMed ID: 17041753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
    Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
    Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
    Esteve M; Saro C; González-Huix F; Suarez F; Forné M; Viver JM
    Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sickness-like reactions in patients receiving intravenous infliximab.
    Gamarra RM; McGraw SD; Drelichman VS; Maas LC
    J Emerg Med; 2006 Jan; 30(1):41-4. PubMed ID: 16434333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab treatment of rheumatoid arthritis and Crohn's disease.
    Nahar IK; Shojania K; Marra CA; Alamgir AH; Anis AH
    Ann Pharmacother; 2003 Sep; 37(9):1256-65. PubMed ID: 12921510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab (Remicade) for Crohn's disease.
    Med Lett Drugs Ther; 1999 Feb; 41(1047):19-20. PubMed ID: 10076592
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
    Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
    Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local injection of Infliximab for the treatment of perianal Crohn's disease.
    Poggioli G; Laureti S; Pierangeli F; Rizzello F; Ugolini F; Gionchetti P; Campieri M
    Dis Colon Rectum; 2005 Apr; 48(4):768-74. PubMed ID: 15768185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab in the surgical management of complex fistulating anal Crohn's disease.
    Talbot C; Sagar PM; Johnston MJ; Finan PJ; Burke D
    Colorectal Dis; 2005 Mar; 7(2):164-8. PubMed ID: 15720356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease.
    Miheller P; Muzes G; Lakatos G; Mihály E; Tulassay Z
    J Emerg Med; 2007 Feb; 32(2):209-10; author reply 210. PubMed ID: 17307639
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease.
    Candon S; Mosca A; Ruemmele F; Goulet O; Chatenoud L; Cézard JP
    Clin Immunol; 2006 Jan; 118(1):11-9. PubMed ID: 16125467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: biological drugs in Crohn's disease.
    Kamm MA
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():80-9. PubMed ID: 16961751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease.
    Brown SJ; Abreu MT
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):160-8. PubMed ID: 15782540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab in Crohn's disease: a look at the (not so distant) future.
    Sorrentino D; Terrosu G; Avellini C
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S229-35. PubMed ID: 18598994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for treatment with infliximab for Crohn's disease.
    Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
    Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.